• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dentsply Sirona Sustainability Report 2023: Year of continued action leads to strong results and several goals achieved ahead of time

    10/15/24 8:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care
    Get the next $XRAY alert in real time by email

    Since the launch of its sustainability strategy "BEYOND: Taking Action for a Brighter World" in 2021, Dentsply Sirona has worked diligently to advance sustainability within the company as well as throughout the industry. Dentsply Sirona's latest sustainability report is renewed evidence of the great dedication the company and its employees bring to the table every day.

    CHARLOTTE, N.C., Oct. 15, 2024 /PRNewswire/ -- Dentsply Sirona, the world's largest manufacturer of professional dental products and technologies and a leading provider of continence care solutions, published its 2023 Sustainability Report over the past weekend during DS World Las Vegas. This annual clinical education event for dental professionals was the perfect platform for unveiling the company's sustainability achievements and commitments, allowing attendees to engage with Dentsply Sirona's vision for a more sustainable future.

    Fig. 1: Dentsply Sirona's Sustainability Report 2023

    The report shows strong overall progress against its goals for the fourth year in a row as well as several goals met ahead of their 2025 timeframe. Guided by its sustainability strategy "BEYOND: Taking Action for a Brighter World", Dentsply Sirona has achieved positive impact along its three pillars: Healthy Planet (environmental goals), Healthy Smiles (social goals) and Healthy Business (governance goals).

    Highlights from the 2023 Sustainability Report include but are not limited to:

    • Significant reduction of Scope 1 and 2 GHG emissions intensity by 47% compared with the baseline measurement from 2019.1 Goal achieved ahead of original 2025 timeframe, exceeding the original 15% reduction target.
    • Reduction of water withdrawal intensity by 29% compared with the baseline measurement from 2019. Goal achieved ahead of original 2025 timeframe, exceeding the original 15% reduction target.
    • We continue to progress towards our Net Zero in Scope 1 -3 carbon emissions by 2050.
    • Continued to drive sustainable change within the dental industry and beyond through strong partnerships, the sharing of knowledge, donations of funds, products and time. Examples of engagement include the long-standing partnership with Smile Train, the world's largest cleft-focused organization, and support for FDI World Dental Federation's initiatives World Oral Health Day and Sustainability in Dentistry.
    • Enabled and empowered over 5.5 million smiles2 from across our communities, dental professionals, and employees, contributing to more than 16.8 million smiles since 2021 and on track to enable 25 million smiles by 2025.
    • Completed global gender pay parity analysis and based on data from the first half of 2024, the company has achieved total average gender pay parity across our global workforce, ahead of the 2025 target.
    • 54% of global hires in 2023 were diverse3 and the global gender parity was 44%.
    • More than 10,300 employee registrations to diversity, equity and inclusion trainings and awareness programs.
    • Hosted more than 9,200 educational courses for customers in over 80 countries in 2023, including the Sustainability Educational Course – an increase of over 2,000 courses compared to 2022.4
    • Continued to place the utmost importance on a safe working environment, reducing even further the number of recordable incidents at Dentsply Sirona. A top decile injury and illness prevention rate of 0.17 was achieved in 2023, surpassing the original goal of 0.27 by 2025.5  

    "We are very pleased with the progress we have made since 2021 and especially the strong results we achieved over the course of the last year", said Tony Johnson, SVP, Chief Supply Chain Officer and Executive Sponsor for ESG at Dentsply Sirona. "This continued success motivates us to put even more fervour into reducing our environmental footprint, improving oral health and continence care globally, creating a diverse, equitable, inclusive, and respectful culture as well as establishing processes that ensure integrity, transparency, and responsibility at all levels of our business."

    "The strong outcomes of the past year are evidence of our steadfast commitment to sustainability. 2023 was a year of action, where we continued to transform oral health and continence care services through innovative products and solutions. Everyone at Dentsply Sirona has pulled together and ensured that we were able to 'Win as One', driving sustainability and innovation, while protecting our business, our customers and their patients," said Simon Campion, President and CEO at Dentsply Sirona. "I am proud of what we have achieved together and confident that we will continue to make great strides for sustainability, as we continue to go BEYOND, improving lives worldwide and contributing to a healthy future for our planet."

    The 2023 Dentsply Sirona Sustainability Report

    is available for Download on the website.

    For more information on Dentsply Sirona's sustainability strategy BEYOND, visit https://www.dentsplysirona.com/en/company/our-sustainability.html.

    IMAGES

    are available for Download on the website.

    Press Contact

    Marion Par-Weixlberger | Vice President Public Relations & Corporate Communications

    Sirona Straße 1 | 5071 Wals bei Salzburg, Austria | T  +43 (0) 662 2450-588 | F  +43 (0) 662 2450-540

    [email protected] | www.dentsplysirona.com

    Edelman GmbH

    Schöneberger Straße 15 | 10963 Berlin, Germany | T +49 (0) 173 781 2582

    [email protected] | www.edelman.com

    About Dentsply Sirona

    Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands.

    Dentsply Sirona's products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care.

    Dentsply Sirona's headquarters is located in Charlotte, North Carolina. The company's shares are listed in the United States on Nasdaq under the symbol XRAY.

    Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

    1 We calculate Scope 1 and 2 GHG emissions intensity by dividing the total level of emissions by net sales.

    2 This figure is comprised of our community oral healthcare delivery initiatives and donations; Clinical Education programs and educational events for dental professionals (for example, DS World); inclusion, empowerment and benefit programs offered to employees; and product solutions that restore smiles – primarily through single treatment (for example, CEREC). We ensure we do not double count year-over-year figures from our internal programs, and we work with partners to calculate external figures for our community programs. There are some instances when we have to use estimated figures due to data privacy reasons or internal data has not been externally assured.

    3 All global employees who self-identify as female, or people of color in the U.S.

    4 Includes training courses to dental professionals through in-person, online, and hybrid formats; excludes courses provided by Wellspect.

    5 Top decile based on American Chemistry Council medium sized member company total recordable injury rates.

    Registered brands, trade names and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials.

    Fig. 2: Overview of selected stand-out 2023 sustainability achievements

    Dentsply Sirona Logo (PRNewsfoto/Dentsply Sirona)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dentsply-sirona-sustainability-report-2023-year-of-continued-action-leads-to-strong-results-and-several-goals-achieved-ahead-of-time-302276309.html

    SOURCE Dentsply Sirona

    Get the next $XRAY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XRAY

    DatePrice TargetRatingAnalyst
    4/15/2026$10.00Sell
    Citigroup
    2/19/2026$17.00Neutral → Buy
    BofA Securities
    12/9/2025$12.00Underweight
    Barclays
    11/7/2025Outperform → Mkt Perform
    William Blair
    4/15/2025$14.00Overweight → Equal-Weight
    Morgan Stanley
    3/13/2025Buy → Hold
    Needham
    2/14/2025$20.00Equal Weight
    Wells Fargo
    1/23/2025$30.00 → $20.00Buy → Hold
    Jefferies
    More analyst ratings

    $XRAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup initiated coverage on Dentsply Sirona with a new price target

    Citigroup initiated coverage of Dentsply Sirona with a rating of Sell and set a new price target of $10.00

    4/15/26 8:07:52 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona upgraded by BofA Securities with a new price target

    BofA Securities upgraded Dentsply Sirona from Neutral to Buy and set a new price target of $17.00

    2/19/26 7:47:02 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Barclays initiated coverage on Dentsply Sirona with a new price target

    Barclays initiated coverage of Dentsply Sirona with a rating of Underweight and set a new price target of $12.00

    12/9/25 8:44:01 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics

    Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI1 (ddMRI) system – MAGNETOM Free.Max Dental Edition – has received FDA clearance in the United States. This milestone follows the completion of a clinical trial2 validating the system's significant potential across multiple dental specialties. The trial highlighted this first-of-its-kind technology's applicability in endodontics, periodontics, TMJ, tooth extraction, and orthodontics, offering non-ionizing imaging capabilities that can enhance diagnosis and treatment planning. CHARLOTTE, N.C., March 09, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona and Siemens Healthineers are pleased to sha

    3/9/26 8:30:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026

    CHARLOTTE, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare Conference. Management is scheduled to present on Tuesday, March 10, 2026, at 10:00 a.m. EST. Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com. About Dentsply Sirona Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation

    3/3/26 4:15:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook

    News Summary Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5%Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of taxQ4 2025 adjusted EPS of $0.27FY 2026 outlook: net sales in the range of $3.5B to $3.6B; adjusted EPS of $1.40 to $1.50(1)Announced a restructuring initiative to redirect approximately $120 million annually into the Return-to-Growth Action Plan, prioritizing investments in accelerated innovation, clinical education, and sales team education focused on connected dentistryInitiated new capital allocation strategy by eliminating the dividend

    2/26/26 4:01:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by DENTSPLY SIRONA Inc.

    SCHEDULE 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    3/26/26 6:04:32 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by DENTSPLY SIRONA Inc.

    10-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    2/26/26 4:54:01 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    DENTSPLY SIRONA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    2/26/26 4:13:30 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lucier Gregory T bought $186,675 worth of shares (15,000 units at $12.45) (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/9/26 4:20:49 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Forbes James D bought $62,400 worth of shares (5,000 units at $12.48), increasing direct ownership by 100% to 10,000 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/9/26 4:19:42 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Director Lucier Gregory T bought $707,379 worth of shares (50,000 units at $14.15) (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/3/26 7:12:19 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    Leadership Updates

    Live Leadership Updates

    View All

    Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors

    CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointments of James (Jim) D. Forbes and Brian P. McKeon to its Board of Directors (the "Board"), effective February 27, 2026. Mr. Forbes is a veteran healthcare investment banker with 30 years of experience helping companies develop strategies to drive profitable growth and long-term value creation. Mr. Forbes is widely recognized for advising healthcare companies on complex strategic transactions and capital markets engagements. He most recently served as Vice Chairman of Investment Banking at Morgan Stanley, and he previously held senior execu

    2/24/26 4:30:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints Donald Zurbay to Board of Directors

    CHARLOTTE, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointment of Donald (Don) Zurbay to its Board of Directors (the "Board"), effective January 10, 2026. He will be joining the Board's Audit and Finance Committee. Mr. Zurbay brings extensive leadership experience in the dental and healthcare industries, and value creation across complex, global organizations. He most recently served as President and Chief Executive Officer (CEO) of Patterson Companies, following his tenure as Chief Financial Officer (CFO) from 2018 to 2022. During his tenure, Patterson maintained a longstanding dealer partnership

    1/13/26 8:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization

    CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization, effective January 28. The appointment supports Dentsply Sirona's continued focus on strengthening commercial execution, deepening customer relationships and accelerating growth across the Americas. Mr. Bezjak is a seasoned commercial executive with more than 20 years of experience leading large-scale, multi-billion-dollar organizations in the medical device

    1/12/26 9:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    Financials

    Live finance-specific insights

    View All

    Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook

    News Summary Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5%Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of taxQ4 2025 adjusted EPS of $0.27FY 2026 outlook: net sales in the range of $3.5B to $3.6B; adjusted EPS of $1.40 to $1.50(1)Announced a restructuring initiative to redirect approximately $120 million annually into the Return-to-Growth Action Plan, prioritizing investments in accelerated innovation, clinical education, and sales team education focused on connected dentistryInitiated new capital allocation strategy by eliminating the dividend

    2/26/26 4:01:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26

    CHARLOTTE, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, February 26, 2026, at 4:30 p.m. EST to review its fourth quarter and full year 2025 financial results. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast will be available on the Investors section of the Company's website at http

    2/5/26 4:15:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Declares Quarterly Cash Dividend

    CHARLOTTE, N.C., Dec. 15, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share. The dividend is payable on January 9, 2026, to holders of record as of December 26, 2025. About Dentsply Sirona Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including den

    12/15/25 8:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

    SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    12/6/24 10:11:29 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

    SC 13G - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    11/14/24 1:22:35 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

    SC 13G - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    11/12/24 4:23:31 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $XRAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Mazelsky Jonathan Jay

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    4/2/26 5:09:02 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by President, CEO & Member of BOD Scavilla Daniel T

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/12/26 5:44:35 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by EVP, Chief Commercial Officer Denti Aldo Mariano Roberto

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    3/12/26 5:41:09 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care